161 related articles for article (PubMed ID: 16750503)
21. [Pituitary carcinoma].
Nishioka H; Yamada S; Fukuhara N
Nihon Rinsho; 2011 Mar; 69 Suppl 2():212-6. PubMed ID: 21830545
[No Abstract] [Full Text] [Related]
22. Treatment of pituitary carcinomas and atypical pituitary adenomas: a review.
Hirohata T; Ishii Y; Matsuno A
Neurol Med Chir (Tokyo); 2014; 54(12):966-73. PubMed ID: 25446382
[TBL] [Abstract][Full Text] [Related]
23. Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide.
Matsuno A; Murakami M; Hoya K; Yamada SM; Miyamoto S; Yamada S; Son JH; Nishido H; Ide F; Nagashima H; Sugaya M; Hirohata T; Mizutani A; Okinaga H; Ishii Y; Tahara S; Teramoto A; Osamura RY
Med Mol Morphol; 2014 Mar; 47(1):1-7. PubMed ID: 23955641
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection.
Touma W; Hoostal S; Peterson RA; Wiernik A; SantaCruz KS; Lou E
J Clin Neurosci; 2017 Jul; 41():75-77. PubMed ID: 28291643
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of a child with a prolactin secreting macroadenoma with temozolomide.
Felker J; Patterson B; Wrubel D; Janss A
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1413-1415. PubMed ID: 27815961
[TBL] [Abstract][Full Text] [Related]
26. Pituitary carcinoma presenting with multiple metastases: case report.
Guzel A; Tatli M; Senturk S; Guzel E; Cayli SR; Sav A
J Child Neurol; 2008 Dec; 23(12):1467-71. PubMed ID: 19073854
[TBL] [Abstract][Full Text] [Related]
27. Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series.
Padovan M; Cerretti G; Caccese M; Barbot M; Bergo E; Occhi G; Scaroni C; Lombardi G; Ceccato F
Expert Rev Endocrinol Metab; 2023 Mar; 18(2):181-198. PubMed ID: 36876325
[TBL] [Abstract][Full Text] [Related]
28. Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review.
Curtò L; Torre ML; Ferraù F; Pitini V; Altavilla G; Granata F; Longo M; Hofland LJ; Trimarchi F; Cannavò S
ScientificWorldJournal; 2010 Nov; 10():2132-8. PubMed ID: 21057727
[TBL] [Abstract][Full Text] [Related]
29. Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?
Erridge SC; Gregor A
Nat Clin Pract Oncol; 2005 Apr; 2(4):194-5. PubMed ID: 16264933
[No Abstract] [Full Text] [Related]
30. Radiotherapy plus concomitant and adjuvant temozolomide for leptomeningeal pilomyxoid astrocytoma: a case study.
Enting RH; van der Graaf WT; Kros JM; Heesters M; Metzemaekers J; den Dunnen W
J Neurooncol; 2006 Oct; 80(1):107-8. PubMed ID: 16645715
[No Abstract] [Full Text] [Related]
31. Treatment of aggressive prolactinoma with temozolomide: A case report and review of literature up to date.
Chen C; Yin S; Zhang S; Wang M; Hu Y; Zhou P; Jiang S
Medicine (Baltimore); 2017 Nov; 96(47):e8733. PubMed ID: 29381964
[TBL] [Abstract][Full Text] [Related]
32. Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm.
Syro LV; Uribe H; Penagos LC; Ortiz LD; Fadul CE; Horvath E; Kovacs K
Clin Endocrinol (Oxf); 2006 Oct; 65(4):552-3. PubMed ID: 16984254
[No Abstract] [Full Text] [Related]
33. Response to low dose temozolomide in radiation induced gliomatosis cerebri.
Hargrave D; Bouffet E; Gammon J; Becker L; Rutka J; Baruchel S
Med Pediatr Oncol; 2003 Dec; 41(6):562-4. PubMed ID: 14595716
[No Abstract] [Full Text] [Related]
34. [Recent advances in the medical treatment of glioma-temozolomide].
Nishikawa R
No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
[No Abstract] [Full Text] [Related]
35. Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
Reni M; Ferreri AJ; Landoni C; Villa E
J Natl Cancer Inst; 2000 Apr; 92(7):575-6. PubMed ID: 10749917
[No Abstract] [Full Text] [Related]
36. Treatment of brain metastases of malignant melanoma with temozolomide.
Biasco G; Pantaleo MA; Casadei S
N Engl J Med; 2001 Aug; 345(8):621-2. PubMed ID: 11529230
[No Abstract] [Full Text] [Related]
37. Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.
Chan AT; Leung TW; Kwan WH; Mok TS; Yeo W; Lai M; Johnson PJ
Cancer Chemother Pharmacol; 1998; 42(3):247-9. PubMed ID: 9685061
[TBL] [Abstract][Full Text] [Related]
38. Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma.
Mendola M; Passeri E; Ambrosi B; Corbetta S
J Clin Endocrinol Metab; 2014 Aug; 99(8):2623-4. PubMed ID: 24823463
[No Abstract] [Full Text] [Related]
39. Temozolomide treatment of an adult with a relapsing medulloblastoma.
Durando X; Thivat E; Gilliot O; Irthum B; Verrelle P; Vincent C; Bay JO
Cancer Invest; 2007 Sep; 25(6):470-5. PubMed ID: 17882660
[TBL] [Abstract][Full Text] [Related]
40. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
Hamilton DA
Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
